DNA-Based Customized Vitamin Formulations Market Size & Share 2025 - 2034

DNA-Based Customized Vitamin Formulations Market Size

The global DNA-based customized vitamin formulations market was estimated at USD 520 million in 2024. The market is expected to grow from USD 623.6 million in 2025 to USD 2.4 billion in 2034, at a CAGR of 16.4% according to latest report published by Global Market Insights Inc.

• The strong and continuing growth of the DNA-based custom-made vitamins market is supplemented with the applications generated by the combined advancement in the technology of genetic tests and consumer awareness for health encouraged with a growing number of chronic diseases people suffering from them can benefit from more personalized nutritional approaches.
   
• This is a niche sector but has been flourishing along with the rest of the personalized nutrition market. DNA vitamin solutions find uptake from customers and new clients because of the technological advances that have made genetic testing cheaper and easier to access.
   
• Growth is still somewhat limited relative to the global supplement industry, pointing to room for considerable expansion. Its target market reaches millions of adults who regularly consume dietary supplements, while some of the bright prospects are emerging from parts of the world where digital health infrastructure is expanding rapidly.
   

DNA-Based Customized Vitamin Formulations Market Trends

• This shift in the market is massive; advanced technology meets the evolving potential of consumers. AI and machine learning transform that personalization by running multi-omics platforms analyzing genetic variants and biomarkers to adequately recommend nutrients. These systems constantly learn from user feedback as well as scientific updates to make them more efficacious and retain customers. All this would make an AI core differentiator on personalized nutrition.
   
• Wearable device convergence opens ways of adaptive supplementation protocols. The addition of real-time information from health trackers with insights drawn from genetics allows firms to change formulations with respect to sleep, stress, and activity-children's lifestyle conditions. This boosting engagement inside the mind of the consumer has led to a heightened standard of living in data-responsive wellness solutions.
   
• Wellness ecosystems are evolving as they relate to the markets. Personalized nutrition platforms have end-to-end offerings the entire continuum from genetic testing to nutritional analysis to supplements to health tracking and create great cross-sell opportunities and a viable basis for a premium pricing model. Advanced regulatory efforts and a microbiome will enhance credibility and precision in terms of personalization so that they will be competitive advantages among early adopters and will account for continuous long-term growth.
   

DNA-Based Customized Vitamin Formulations Market Analysis

Based on technology type, the market is segmented into single nucleotide polymorphism (SNP), next-generation sequencing (NGS), microarray technology, and real-time PCR. The single nucleotide polymorphism (SNP)dominated the market with an approximate revenue share of 57.8% in 2024 and is expected to grow with a CAGR of 14.9% through 2034.
 

• SNP analysis remains the lead technology by far, promising earnestly cost-effectiveness, clinical validity, and certain approaches related to nutrigenomics. An excellent selection of genetic variants affecting nutrient metabolism has been considered for this approach since recommendations for important vitamins and minerals could be made with incredible precision. Since the technology is quite mature and cheap, it has been the darling of consumer markets, and with more growth due to expanded variant panels and improved interpretation received in the future.
   
• NGS is an acute segment growing owing to global genome surveying. On the road to personalization, NGS provides insight into rare genetic variants and complex interactions showing how nutrient requirements may differ. NGS fascinates the high-end customers looking for health optimization which is accelerated further by lowering sequencing costs and a better bioinformatics infrastructure.
   
• All these technologies reinvent the DNA-based supplement landscape. While SNP analysis has a broader market appeal with higher precision, NGS paves the way for further personal recognition for the high-end segment. By the time these technologies evolve, a merger between the two seems likely to allow brands to provide multiple service levels balancing affordability with depth of insight.

Learn more about the key segments shaping this market

Download Free PDF

Based on applications, the DNA-based customized vitamin formulations market is segmented into vitamin deficiency assessment, metabolic health optimization, athletic performance enhancement, aging & longevity support. The vitamin deficiency assessment holds the largest market share of 43.5% in 2024 and is expected to grow at a CAGR of 16.1% during 2025 to 2034.
 

• Vitamin deficiency assessment has shaped application area, as they have formed the basis for uncovering the genetic disposition to nutrient absorption and utilization challenges. Expanded validity attests to it and the application is further weaved into preventive health protocols. Awareness on the role of genetic factors on vitamin status is gaining traction. Unsurprisingly, consumers and healthcare providers alike are thus going for DNA-based solutions for very accurate and predictive nutritional planning.
   
• The metabolic health optimization vertical has also begun to attain fruitful consequences in personalized medicine, interestingly through elucidation of genetic variants that may have an impact on glucose regulation and obesity and cause some life-altering metabolic syndrome. In contrast to traditional medicine, nutrition recommendations are being pursued on a per-person basis glucose regulation, reduced inflammation, and energy support, for maintenance of holistic metabolic wellness. Besides, it is complemented by support from digital health tools, such as the integration of glucometers and personalized nutrition platforms.
   
• Through all those applications the market shift towards precision wellness, and so DNA-based products are no longer adjacent to clinical nutrition but instead offer very targeted interventions for certain health/state conditions. This evolution brings a new meaning for consumers and healthcare providers by making personalized nutrition a cardinal element of future healthcare and lifestyle management.
   

Based on distribution channel, the DNA-based customized vitamin formulations market is segmented into direct-to-consumer (DTC), healthcare providers, retail pharmacies, specialty nutrition stores. Direct-to-consumer (DTC) segment dominated the market with an approximate 53.6% share in 2024 and is expected to grow with the CAGR of 16.2% through 2034.
 

• DTC platforms are creating unprecedented accessibility and personalization of mass marketing. These channels use digital health to send genetic test kits and personalized supplement subscriptions straight to the consumer. The DTC convenience, privacy, and personalization connect well with savvy consumers who are health oriented.
   
• DNA-based vitamin formulations are rapidly being integrated into preventive and therapeutic care by healthcare professionals. Clinical-grade genetic information is guiding personal supplementation recommendations towards nutrient deficiencies, metabolic health, and chronic condition-influenced sheer healthcare. This channel further benefits from growing medical professional trust into genomics and expanding reimbursement coverage, thereby creating a high credibility path for market access and long-term adoption.
   
• Retail pharmacy and specialty nutrition stores are crucial points of education and product discovery for consumers. These outlets sell DNA-based supplements in consumer-friendly formats, sometimes packaged with basic genetic screening services. Although retail channels may be limited in the level of personalization that they can achieve compared to their digital counterparts, they serve as crucially important mediums for cementing the legitimacy of the category among consumers who prefer to consult in person and gain immediate access to products.

The North America dominated the global DNA-based customized vitamin formulations market with a revenue share of 44.2% in 2024.
 

• Well-advanced healthcare infrastructure, consumer awareness, and enabling regulatory environment is the reason to keep North America on the lead. Established acceptance of direct-to-consumer genetic testing procedures obviously favors regional growth since companies like 23andMe have achieved Counts more than 12million customers by 2024. The increasing healthcare costs have persuaded consumers to adopt preventive approaches, thereby driving market growth; such tests are being integrated into clinical practice, and the funding of personalized nutrition startups is being backed with strong venture capital inputs.
   

U.S. dominates the North America DNA-based customized vitamin formulations market, showcasing strong growth potential.
 

• The growth of the region in the United States is supported by clear FDA regulations for genetic tests, CLIA-certified laboratory infrastructure, and readiness of consumers to pay premium prices for personalized health solutions. Conversely, Canadian growth is supported with government health initiatives backing precision medicine and increasing consumer adoption of digital health platforms.
   

Europe DNA-based customized vitamin formulations market accounted for USD 497.2 million in 2024 and is anticipated to show lucrative growth over the forecast period.
 

• Distribution channels across Europe are increasingly diversifying. The DTC models are very much becoming popular with customers because of their convenience and ability to personalize a solution. It has, however, managed to meet the needs of health institutions, which are starting to apply DNA-based formulations for clinical nutrition and the management of chronic conditions. The contribution of retail pharmacies and specialty nutrition stores in transforming this category continues in making it more accessible formats and education for consumers who first encounter personalized nutrition.
   

Germany dominates the European DNA-based customized vitamin formulations market, showcasing strong growth potential.
 

• Countries like Germany, the UK, France, and Italy experience increased purchase of DNA-based supplements, particularly luxury brands and ingredient partnerships on B2B lines. For their part, the retailers are improving microbiome literacy and transparency over products, giving scope to consumers to characterize traditional ones from modern ones based on genetic insight formulations.
   
• Germany commands the European market because of its generalized industry participation, active research on microbiome sciences, and consumers receptive to functional nutrition.
   

The Asia Pacific DNA-based customized vitamin formulations market is anticipated to grow at a CAGR of 21.9% during the analysis timeframe.
 

• Asia Pacific is becoming the fastest-growing region in the market, propelled by increasing health awareness, penetration of digital healthcare, and a burgeoning middle class. Nations such as China, India, and Japan welcome personalized nutrition that marries age-old wellness practices with modern genomic science. These two factors, openness to innovation and an increasing number of consumers demanding targeted health solutions, considerably speed up the market growth.
   

China DNA-based customized vitamin formulations market is estimated to grow with a significant CAGR in the Asia Pacific region.
 

• China, in turn, seeks to be a strategic hub for growth, with digital health platforms and e-commerce channels captivating much momentum. Gut health, immunity, and functional nutrition are therefore driving demand for DNA-personalized supplements. Local companies are investing money and resources in research and product development, thus aligning themselves with national priorities toward health modernization and personalized care.
   

Latin America DNA-based customized vitamin formulations market accounted for 4.9% share in 2024 and is anticipated to show lucrative growth over the forecast period.
 

• With urbanization, health consciousness, and digital health access increasing Latin America emerges as a developing region of promise for DNA-driven personalized vitamin formulations. Consumers are gravitating toward personalized wellness options in line with plant-based and functional nutrition regional preferences. This move created a new platform for local manufacturers to think of DNA-personalized supplements in many formats, from fortified foods to daily wellness products.
   

Brazil leads the Latin American DNA-based customized vitamin formulations market, exhibiting remarkable growth during the analysis period.
 

• An active consumer community within Brazil demanding convenient immunity and gut health products fuels the entire industry here. Brazilian companies are developing differentiated products that marry local knowledge in nutrition sciences and wellness trends with DNA insights.
   

Middle East & Africa DNA-based customized vitamin formulations market accounted for 3.5% share in 2024 and is anticipated to show lucrative growth over the forecast period.
 

• Urbanization is increasingly health-aware consumers, and wellness innovations are some of the key factors driving the requirement for DNA-based personalized vitamin formulations in the Middle East and Africa. The products promise immediate and long-term health benefits, and for these reasons, consumers are searching for customized offerings under clean labels and functional health umbrellas. This change is making companies in the area innovate supplements on the basis of genomics, considering local diets and the prevalent health priorities.
   

Saudi Arabia DNA-based customized vitamin formulations market is expected to experience substantial growth in the Middle East and Africa in 2024.
 

• This landscape allows healthcare infrastructure, food innovation programs, and consumer demand for convenience through wellness products, which puts the bill for the emerging attractive market. Just personalizing nutrition formats into modern approaches would be able to introduce DNA-based supplements into retail and institutional markets in Saudi Arabia.
   

DNA-Based Customized Vitamin Formulations Market Share

The top 5 companies in DNA-based customized vitamin formulations industry include 23andMe Inc., Persona Nutrition, Viome Life Sciences, DNAfit (Prenetics), Nutrigenomix Inc. These are prominent companies operating in this market constitute around 33% of the market share in 2024. These companies hold strong positions due to their extensive experience in DNA-based customized vitamin formulations industry. Their diverse product portfolios, backed by robust production capabilities and distribution networks, enable them to meet the rising demand across various regions.
 

• 23andMe, Inc. is a consumer genetics and biotechnology company providing direct-to-consumer genetic testing services in ancestry, health traits, and wellness, having further expanded its business into personalized health territories, including DNA-based supplement recommendation through its digital platform.
   
• Persona Nutrition is a personalized supplement service that utilizes health assessments and lifestyle data to propose tailor-made vitamin packs. In its personalization model, it also incorporates genetic testing and provides curated daily supplement regimens directly to the consumer.
   
• Viome Life Sciences targets precision health with the analysis of microbiome and gene expression. It makes personalized nutrition and supplement recommendations based on RNA sequencing and AI insights aimed at gut health, immunity, and metabolism.
   
• DNAfit, a Prenetics company, specializes in genetic testing focused on fitness, nutrition, and wellness. It offers personalized reports and supplement recommendations that use genetic markers related to diet, exercise, and nutrient metabolism.
   
• Nutrigenomix Inc. is a biotechnology company specializing in genetic testing for personalized nutrition. Collaborates with healthcare professionals to provide DNA-based information to inform dietary and supplement choices, with application in general wellness, athletic performance, and clinical nutrition.
   

DNA-Based Customized Vitamin Formulations Market Companies

Major players operating in the DNA-based customized vitamin formulations industry include:
 

• 23andMe Inc.
• Persona Nutrition
• Viome Life Sciences
• DNAfit (Prenetics)
• Nutrigenomix Inc.
• Rootine
• InsideTracker
• GenoPalate
• Care/of
• Habit (Campbell Soup Company)
• Season Health
• Bioniq
• Xcode Life
• Mapmygenome
• Avesthagen
   

DNA-Based Customized Vitamin Formulations Industry News

• In January 2025, strategic partnership between Viome Life Sciences and the Mayo Clinic to carry out clinical validation studies for its microbiome-based personalized nutrition recommendations, a huge step toward being adopted by healthcare providers or attaining insurance coverage for personalized nutrition services.
   
• In December 2024, 23andMe, Inc. launched its enhanced Nutrition Reports with the analysis of 75+ genetic variants that affect nutrient metabolism, which is an expansion of the original health reports to make concrete supplement recommendations based on genetic predisposition to vitamin deficiencies and metabolic variations.
   
• In November 2024, Persona Nutrition closed its $25 million Series B funding round, with Bessemer Venture Partners as the round's leader, for the development of the AI platform and the expansion into European markets via partnerships with local healthcare providers and wellness clinics.
   

This DNA-based customized vitamin formulations market research report includes in-depth coverage of the industry, with estimates & forecasts in terms of revenue (USD Million) and volume (Kilo Tons) from 2025 to 2034, for the following segments:

Click here to Buy Section of this Report

Market, By Technology Type

• Single nucleotide polymorphism (SNP)
• Next-generation sequencing (NGS)
• Microarray technology
• Real-time PCR

Market, By Application

• Vitamin deficiency assessment
• Metabolic health optimization
• Athletic performance enhancement
• Aging & longevity support

Market, By Distribution Channel

• Direct-to-consumer (DTC)
• Healthcare providers
• Retail pharmacies
• Specialty nutrition stores

The above information is provided for the following regions and countries:

• North America  
  • U.S.
  • Canada
• Europe  
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe 
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Rest of Asia Pacific 
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America 
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of Middle East and Africa